DTC
AGIO icon

Deep Track Capital’s Agios Pharmaceuticals AGIO Stock Holding History

Deep Track Capital’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,062,881
Closed -$23.7M – 68
2023
Q4 		$23.7M Buy
1,062,881
+640,634
+152% +$14.4M 0.79% 45
2023
Q3 		$10.5M Buy
+422,247
New +$11.2M 0.4% 48

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Deep Track Capital's AGIO Position: Q1 2024 in Review

Deep Track Capital sold out of Agios Pharmaceuticals (AGIO) in Q1 2024, closing a stake of 1,062,881 shares — an estimated $23.7M sold.

Deep Track Capital first reported a position in AGIO in Q3 2023 and held it in 2 quarters. The position peaked at $23.7M in Q4 2023. 186 funds tracked by Wall St. Rank hold AGIO as of Q1 2024.

  • Deep Track Capital reported no remaining Agios Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Deep Track Capital sold 1,062,881 Agios Pharmaceuticals shares in Q1 2024, an estimated $23.7M.
  • Deep Track Capital first reported a position in Agios Pharmaceuticals in Q3 2023 and held it in 2 quarters.
  • Deep Track Capital's Agios Pharmaceuticals position peaked at $23.7M in Q4 2023.
  • 186 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2024.

Based on Deep Track Capital's 13F filing for Q1 2024, filed 15 May 2024.